FDAnews Drug Daily Bulletin

SYMBOLLON PHARMACEUTICALS ANNOUNCES THIRD QUARTER 2005 RESULTS

Nov. 23, 2005
A A

Symbollon Pharmaceuticals, Inc. (OTC BB: SYMBA) today announced a net income for the quarter ended September 30, 2005. For the three months ended September 30, 2005, the Company reported a net income of $38,395, or a diluted income per share of $0.00, compared with a net loss of $471,275, or a diluted loss per share of $0.09 in the prior year. For the nine months ended September 30, 2005, the Company reported a net loss of $329,307, or a diluted loss per share of $0.05, compared with a net loss of $2,262,622, or a diluted loss per share of $0.49 in the prior year.

Market Wire (http://www.marketwire.com/mw/release_html_b1?release_id=101963)